CytoSorbents Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Cytosorbents (CTSO) Misses Q3 EPS by 8c
November 5, 2019 5:08 PM ESTCytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.21), $0.08 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $6.66 million.
Total Q3 2019 revenues were $6.1 million, including both product sales and grant income, an increase of... More